HEALTHAL JAZEERA
An extra 229,000 deaths: Is that the cost of US-UK drugs deal?
A research study suggests that a US-UK trade deal requiring the UK to purchase more medicines from the US may divert funds from other areas of the NHS, potentially leading to an additional 229,000 deaths. The analysis links the trade agreement's provisions to reduced healthcare resources in the UK.
Related Signal
Adjacent reporting
- US-UK drug deal could result in 229,000 excess deaths in England, analysis suggests
- Starmer's US trade deal will cost the NHS £45billion and could lead to 229,000 deaths, experts say
- Full list of prescription drugs - including cholesterol-busting medication taken by millions - that could see massive price cuts under Trump's new deal
- Why is the US targeting Germany's drug industry?
- STEPHEN MOORE: Foreign drug price controls are a hidden tax on Americans